Hana Materials Issues KRW 100 Billion in Private Exchangeable Bonds… KRW 90 Billion Allocated for Debt Repayment
Hana Micron announced on the 5th that its subsidiary, Hana Materials, has decided to issue KRW 100 billion worth of private exchangeable bonds (EB). The raised

Hana Micron announced on the 5th that its subsidiary, Hana Materials, has decided to issue KRW 100 billion worth of private exchangeable bonds (EB). The raised funds are scheduled to be used for debt repayment of KRW 90 billion and operating funds of KRW 10 billion. The company explained, "These exchangeable bonds are issued with the registered common shares of Hana Micron held by the subsidiary Hana Materials as the exchange target." These exchangeable bonds carry zero-interest terms, with both the coupon rate and the maturity interest rate set at 0%. The payment date is September 14, 2026, and the maturity date is September 14, 2028. The structure is designed without an early redemption option (Put Option). The exchange price is set at KRW 34,388 per share, and the exchange target consists of 2,907,991 common shares of Hana Micron held by Hana Materials. The exchange request period runs from September 15, 2026, to August 14, 2028, and the exchange price may be adjusted in the event of certain circumstances such as paid-in capital increases, bonus issues, or stock splits. The bonds will be issued to Pipesolution No. 5 LLC through a domestic private placement.
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.
![[Breaking] HLB to Issue Private CB to Raise KRW 30 Billion for New Drug Development and Commercialization](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F580558%2Fe71c71593626b654%2Fvariants%2Fhero.webp&w=1920&q=75)
![[Breaking] Woori Technology Issues KRW 40 Billion Zero-Interest Convertible Bonds to Raise Funds for Nuclear Power and New Businesses](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F08%2F594282%2Fa11e3219b605116c%2Fvariants%2Fhero.webp&w=1920&q=75)
![[Breaking News] Samcheondang Pharmaceutical Corrects European Oral Insulin Clinical Trial Disclosure... "16 Subjects, Total Dosing Marked as 64"](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F581748%2Fed2a73c31f2e2200%2Fvariants%2Fhero.webp&w=1920&q=75)
![[IPO Subscription] KNS Inc. Closes Day 2... Proportional Competition Rate at 2,159.1:1, Subscription Deposits Exceed 3 Trillion Won](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F580134%2F631acbbd8afdeca6%2Fvariants%2Fhero.webp&w=1920&q=75)